Guided Therapeutics (GTHP) Capital Expenditures (2011 - 2022)
Guided Therapeutics (GTHP) reported Capital Expenditures of $3000.0 for Q4 2022, down 90.32% on a YoY basis from $31000.0 in Q4 2021, and up 200.0% sequentially from -$3000.0 in Q3 2022.
Guided Therapeutics (GTHP) Capital Expenditures (2011 - 2022) Analysis & Trends
Guided Therapeutics (GTHP) has 12 years of Capital Expenditures data on file, last reported at $3000.0 in Q4 2022.
- For the quarter ending Q4 2022, Capital Expenditures fell 90.32% year-over-year to $3000.0; the trailing twelve-month figure through Sep 2023 stood at $3000.0 (down 94.92% YoY), and the FY2025 full-year result was $2000.0, changed N/A from the prior year.
- Capital Expenditures grew to $3000.0 in Q4 2022, from -$3000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $84000.0 in Q3 2018 to a low of -$33000.0 in Q2 2018.
- A 5-year average of $6214.3 and a median of $2000.0 in 2021 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 800.0% in 2018 and surged 1300.0% in 2022, its largest moves.
- Tracing GTHP's Capital Expenditures over 5 years: stood at $84000.0 in 2018, then sank by 101.19% to -$1000.0 in 2019, then slumped by 1600.0% to -$17000.0 in 2020, then soared by 282.35% to $31000.0 in 2021, then sank by 90.32% to $3000.0 in 2022.
- Business Quant data shows GTHP's Capital Expenditures at $3000.0 in Q4 2022, -$3000.0 in Q3 2022, and $17000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Dec 31, 2021 | 31,000.00 |
| Sep 30, 2021 | -22,000.00 |
| Sep 30, 2021 | -22,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Sep 30, 2020 | -17,000.00 |
| Sep 30, 2020 | -17,000.00 |
| Jun 30, 2020 | 18,000.00 |
| Jun 30, 2020 | 18,000.00 |